Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia

Schizophrenia Research

Volumn 44, Issue 3, 2000, Pages 193-211

  Northoff, G ^a   Pfennig, A ^a   Krug, M ^a   Danos, P ^a   Leschinger, A ^a   Schwarz, A ^a   Bogerts, B ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Catatonia; GABA; Kinematics; Lorazepam; Movement potentials

Indexed keywords

BENZODIAZEPINE DERIVATIVE; LORAZEPAM; PLACEBO;

ADULT; AKINESIA; ARTICLE; BRAIN CORTEX; BRAIN REGION; CATATONIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTRODE; EVOKED CORTICAL RESPONSE; FEMALE; GABAERGIC SYSTEM; HUMAN; INDEX FINGER; MALE; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER;

ADULT; ANTI-ANXIETY AGENTS; BIOMECHANICS; CATATONIA; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EVOKED POTENTIALS; FEMALE; FRONTAL LOBE; HUMANS; INJECTIONS, INTRAVENOUS; LORAZEPAM; MALE; MOVEMENT; OCCIPITAL LOBE; TIME FACTORS;

EID: 0034283749     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(99)00189-9     Document Type: Article

References (51)

1. Adler L.E., Pecevich M., Nagamoto H. Bereitschaftspotential in Tardive Dyskinesia. Movement Disorders. 4:1989;105-112.
2. Diagnostic Manual of Mental Disorders. 4th edition:1994;American Psychiatric Press, Washinton, DC.
3. Bush G., Fink M., Petrides G., Dowling F., Francis A. Catatonia. Rating scale and standardized examination. Acta Psychiat. Scand. 93:1996;129-143.
4. Chiarenza G.A., Papkostopoulos D., Dini M., Cazullo C.L. Neurophysiological correlates of psychomotor activity in chronic schizophrenics. Electroencephalogr. Clin. Neurophysiol. 61:1985;218-228.
5. Curtin F., Schulz P. Multiple correlations and Bonferroni correction. Biol. Psychiatry. 44:1998;775-777.
6. Deecke L. Planning, preparation, execution and imagery of volitional action. Cogn. Brain Res. 3:1996;59-64.
7. Deecke L., Lang W., Heller H.J., Hufnagel M., Kornhuber H.H. Bereitschaftspotential in patients with unilateral lesions of the supplementary area. J. Neurol. Neurosurg. Psychiatry. 50:1987;1430-1434.
8. Dick J.P.R., Cantello R., Buruma O., Gioux M., Benecke R., Day B.L. The Bereitschaftpotential, L-dopa and Parkinson's disease. Electroencephal. Clin. Neurophysiol. 66:1987;263-274.
9. Dick J.P.R., Rothwell J.C., Day B.L., Cantello R., Buruma O., Gioux M., et al. The Bereitschaftspotential is abnormal in Parkinson's disease. Brain. 112:1989;233-244.
10. Endicott J., Spitzer R., Flies J., et al. The global assessment scale. Arch. Gen. Psychiatry. 33:1976;766-771.
11. Fetz E. Are movement parameters recognizably coded in the activity of single neurons? Behav. Brain Res. 15:1992;679-690.
12. Fink M., Bush G., Francis A. Catatonia: a treatable disorder occaisionally recognized. Directions in Psychiatry. 13:1993;1-7.
13. Gelenberg A.J. The catatonic syndrome. Lancet. 2:1976;1339-1341.
14. Gelenberg A.J. Criteria for the diagnosis of catatonia. Am. J. Psychiatry. 134:1977;462-463.
15. Goldberg H.L., Finnerty R. Comparison of buspirone in two separate studies. J. Clin. Psychiatry. 43:1982;87-91.
16. Greenblatt D., Franke K., Shader R. Analysis of lorazepam and its glucuronide metabolite by electron-capture gas-liquid chromatography. J. Chromatogr. 146:1978;311-320.
17. Guy W. Assessment Manual for Psychopharmacology. 1976.
18. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 32:1959;50-55.
19. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
20. Hikosaka O., Tanaka M., Sakamoto M., Iwamura Y. Deficits in manipulative behaviors induced by local injections of muscimol in the first somatosensory cortex of the conscious monkey. Brain Res. 325:1985;375-380.
21. Hommer D.W., Matsuo V., Wolkowitz O., Chrousos G., Greenblatt D.J., Weingartner H., Paul S.M. Benzodiazepine sensitivity in normal human subjects. Arch. Gen. Psychiatry. 43:1986;542-551.
22. Jahanshahi M., Jenkins I.H., Brown R.G., Marsden C.D., Passingham R.E., Brooks D.J. Self-initiated versus externally triggered movements. Brain. 118:1995;913-933.
23. Kahlbaum K. Die Katatonie oder das Spannungsirresein. Eine Form psychischer Krankheit. 1878;Hirschwald, Berlin.
24. Karaman T., Ozkaynak S., Yaltkaya K., Buyukberker C. Bereitschaftspotential in schizophrenia. Br. J. Psychiatry. 171:1997;31-34.
25. Kay S.R., Opler L.A., Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Rating Manual. 1987;Social and Behavioral Sciences Documents, San Rafael, CA.
26. Kornhuber H.H., Deecke L. Hirnpotentialveränderungen beim Menschen vor und nach Willkürbewegungen. Pflügers Archiv. 281:1964;52.
27. Kubota K. Motor cortical muscimol injection disrupts forelimb movement in freely moving monkeys. NeuroReport. 7:1996;2379-2384.
28. Kubota F., Miyata H., Shibata N., Yarita H. A study of motor dysfunction associated with schizophrenia based on analyses of movement-related cerebral potentials and motor conduction time. Biol. Psychiatry. 45:1999;412-416.
29. Kurata K., Hoffman D. Differential effects of muscimol microinjection into dorsal and ventral aspects of the premotor cortex of monkeys. J. Neurophysiology. 71:1994;1151-1164.
30. Lohr J.B., Wisniewski A.A. Movement Disorders: a Neuropsychiatric Approach. 1987;Guilford Press, New York.
31. MacKinnon C.D., Kapur S., Hussey D., Verrier M.C., Houle S., Tatton W.G. Contributions of the mesial frontal cortex to the premovement potentials associated with intermittent hand movements. Human Brain Mapping. 4:1996;1-22.
32. Marquardt C., Mai N. A computational procedure for movement analysis in handwriting. J. Neurosci. Meth. 52:1994;39-45.
33. Matthew E., Andreason P., Pettigrew K., Carson R., Herscovitch P., King C., Greenblatt D., Paul S. Benzodiazepine receptors mediate regional cerebral blood flow changes in the living human brain. Proc. Natl. Acad. Sci. USA. 92:1995;2775-2779.
34. Miller D., Rezai K., Alliger R., Andreasen N. The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia. Biol. Psychiatry. 41:1997;550-559.
35. Northoff G. Katatonie Einführung in die Phänomenologie Klinik und Pathophysiologie eines psychomotorischen Syndroms. 1997;Enke, Stuttgart.
36. Northoff G., Wenke J., Demisch L., Pflug B. Catatonia: short-term response to lorazepam and dopaminergic metabolism. Psychopharmacology. 122:1995;82-186.
37. Northoff G., Wenke J., Koch A., Eckert J., Pflug B. Ball experiments in akinetic catatonia: deficits of internal initiation and the voluntary generation of movements. Movement Disorders. 12:1995;589-595.
38. Northoff G., Wenke J., Krill W., Pflug B. Ball-experiments in 32 acute akinetic catatonic patients: deficits of internal initiation and generation of movements. Movement Disorders. 10:1995;589-595.
39. Northoff G., Krill W., Eckert J., Russ M., Pflug B. Major differences in subjective experience of akinetic states in catatonic and parkinsonic patients. Cogn. Neuropsychiatry. 3:(3):1998;161-178.
40. Northoff G., Koch A., Wenke J., Eckert J., Pflug B., Bogerts B. Catatonia as a psychomotor disease: a rating scale, subtypes and extrapyramidal motor symptoms. Movement Disorders. 14:(3):1999;404-416.
41. Northoff G., Braus D., Sartorius A., Khoram-Sefat D., Russ M., Eckert J., Herrig M., Leschinger A., Bogerts B., Henn F.A. Reduced activation and altered laterality in two neuroleptic-naive catatonic patients during a motor task in functional MRI. Psychol. Med. 29:1999;997-1002.
42. Northoff G., Steinke R., Czcervenka C., Krause R., Ulrich S., Danos P., Kropf D., Otto H.J., Bogerts B. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J. Neurol. Neurosurg. Psychiatry. 1999;. in press.
43. Oldfield R.C. The assessment and analysis of handedness: the Edinborough Inventory. Neuropsychologia. 9:1971;97-113.
44. Petrides G., Divadeenam K., Bush G., Francis A. Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. Biol. Psychiatry. 42:1997;375-381.
45. Rosebush P., Furlong B., Mazurek M. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation an response to lorazepam. J. Clin. Psychiatry. 51:1990;357-362.
46. Simpson G.M., Angus J.W.S. A rating scale for extrapyramidal side effects. Acta Psychiat. Scand. 212:1970;11-19.
47. Singh J., Knight R.T. Frontal lobe contribution to voluntary movements in humans. Brain Res. 531:1990;45-54.
48. Singh J., Knight R.T., Rosenlicht N., Kotun J.M., Beckley D.J., Woods D.L. Abnormal premovement brain potentials in schizophrenia. Schizophr. Res. 8:1992;31-41.
49. Taylor M. Catatonia. a review of the behavioral-neurologic syndrome. Neuropsychiat. Neuropsychol. Behav. Neurol. 3:1990;48-72.
50. Wang G., Volkow N., Overall J., Hitzemann R., Pappas N., Pascani K., Fowler J. Reproducibility of regional brain metabolic responses to lorazepam. J. Nucl. Med. 37:1996;1609-1613.
51. Wetzel H., Heuser I., Benkert O. Stupor und affektiver Zustand: Besserung psychomotorischer Störung durch Lorazepam und Wiederkehr der Symptome nach der Gabe von Ro 15-1788. J. Nerv. Ment. Dis. 175:1987;4-6.